Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI (NCT02756000) | Clinical Trial Compass
CompletedNot Applicable
Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI
Serbia120 participantsStarted 2016-01
Plain-language summary
The study will compare clinical outcomes between complete revascularization during hospitalization for ST elevation myocardial infarction (STEMI) and intervention after 30 days and intervention based on outpatient non-invasive ischemia testing in patients with multivessel coronary artery disease (MVD) presenting with first ever ST elevation myocardial infarction.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical and electrocardiographic signs of first ever ST elevation myocardial infarction (chest pain lasting less than 12 hours with persistent ST elevation of ≥ 1mm in two contiguous leads on ECG recording)
* Multivessel coronary artery disease (MVD) on initial coronary angiogram, defined as visually assessed stenosis of more than 70% of any of the non-culprit vessels
* Treated with primary PCI of infarct related artery (IRA) only.
Exclusion Criteria:
* Hemodynamically unstable patients defined as presence of cardiogenic shock, intraaortic balloon pump (IABP) implantation and mechanical ventilation prior, during and after primary PCI;
* Presence of significant valvular disease;
* Decision that patient needs to be treated with coronary artery bypass graft (CABG) and/or valvular replacement or reconstruction surgery after initial culprit only PCI;
* Myocardial infarction is caused by stent thrombosis:
* Chronic total occlusion of any of the coronary arteries on initial angiogram;
* Previously treated by CABG surgery;
* Estimated life expectancy less than one year.